SEC filings · customer concentration

Who depends on Fresenius Medical Care Rx

1 listed supplier reports Fresenius Medical Care Rx as a customer worth 10% or more of their revenue, led by Akebia Therapeutics at 30%.

0major customers now
—of revenue from them
1listed suppliers depending on it
2019–2026years covered
Free

Get an email when Fresenius Medical Care Rx's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Suppliers that depend on Fresenius Medical Care Rx

Listed companies whose annual report names Fresenius Medical Care Rx as a customer worth 10% or more of their revenue. If Fresenius Medical Care Rx cuts orders or switches supplier, these are the companies that feel it.

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
Akebia TherapeuticsAKBA30%▼ from 48%FY 2019: 21%FY 2020: 29%FY 2021: 33%FY 2022: 34%FY 2023: 40%FY 2024: 48%FY 2025: 30%7 yearsFY 2025 · filed 26 Feb 2026

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API